Emerge™ Push H7493919020150Recalls & reported problems
Boston Scientific Corporation · PTCA Dilatation Catheter · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729806035), received between Oct 21, 2019 and Jan 2, 2024 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Break” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break3
- Difficult to Advance1
- Material Deformation1
- Material Puncture/Hole1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 2, 2024Break; Break
IT WAS REPORTED THAT DEVICE BREAK OCCURRED. A 1.50MM X 20MM EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATATION. HOWEVER, DURING THE PROCEDURE, THE DEVICE WAS NOTED TO BE DEFECTIVE AND BROKEN. THE DEVICE WAS PULLED AND REMOVED INTACT FROM THE PATIENT'S BODY. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE AND NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18426088 ↗MalfunctionSep 26, 2022Break; Material Deformation; Break; Material Deformation
IT WAS REPORTED THAT A SHAFT BREAK OCCURRED. DURING A PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURE, THE TARGET LESION WAS IN AN AREA OF IN-STENT RESTENOSIS LOCATED IN THE TORTUOUS AND CALCIFIED LEFT ANTERIOR DESCENDING ARTERY. A 1.50MM X 20MM EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATATION. HOWEVER, WHILE TRYING TO ADVANCE, THE SHAFT WAS KINKED AND AFTER SEVERAL ATTEMPTS, THE DEVICE EVENTUALLY BROKE. THE DEVICE WAS PULLED BACK AND REMOVED AS A UNIT WITH NO FRAGMENTS LEFT INSIDE THE PATIENT'S BODY. THE LESION WAS REWIRED AND THE PROCEDURE WAS COMPLETED WITH ANOTHER EMERGE BALLOON CATHETER. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15486438 ↗MalfunctionMar 2, 2021Break; Difficult to Advance; Break; Difficult to Advance
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 1.50MM X 20MM EMERGE PUSH BALLOON CATHETER WAS SELECTED TO USE. HOWEVER, DURING INSERTION, IMMEDIATE RESISTANCE WAS FELT WHILE PUTTING THE BALLOON INTO THE Y-ADAPTER AND GUIDE CATHETER AND THE BALLOON BROKE WHEN PULLED BACK. THE DEVICE WAS REMOVED FROM THE PATIENT AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11402224 ↗MalfunctionOct 21, 2019Material Puncture/Hole; Material Puncture/Hole
IT WAS REPORTED THAT SHAFT HOLE OCCURRED. THE TARGET LESION WAS LOCATED IN A CORONARY VESSEL. A 1.50MM X 20MM EMERGE PUSH BALLOON CATHETER WAS SELECTED FOR USE. HOWEVER, A HOLE WAS NOTED IN THE SHAFT OF THE BALLOON CATHETER. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9215677 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page